A trial shows that myelin repair in humans is possible.
Information from the MS Society website:
‘The results from our Phase 2a clinical trial have shown that bexarotene is capable of regenerating lost myelin – the protective coating that surrounds nerve fibres, which is damaged in MS. Now, a new trial of the diabetes drug metformin will build on this work.
Critical to stopping MS
New research presented at the MSVirtual2020 conference has shown that bexarotene, a drug developed to treat cancer, is able to repair myelin in people with relapsing MS. This is a breakthrough that scientists say is critical to their goal of stopping MS.
Professor Alasdair Coles from the University of Cambridge, who led the research, said: “The lessons we’ve learned are incredibly exciting, as we now have further concrete evidence that remyelination in humans is possible. This discovery gives us confidence that we will stop MS, and will swiftly be taken forward into further studies trialling other potential new myelin repair treatments.” ‘
You can read more on the MS Society website here: https://www.mssociety.org.uk/research/latest-research/latest-research-ne…